TVTX is the official Nasdaq stock exchange ticker symbol for Travere Therapeutics, Inc., a biopharmaceutical enterprise dedicated to identifying, developing, and delivering life-changing therapies for people living with rare kidney and metabolic diseases. The company focuses heavily on advancing innovative treatments through late-stage clinical trials and securing regulatory clearances, making it a closely watched equity among healthcare and biotechnology sector investors.